Stockreport

SELLAS Life Sciences Announces Review of Strategic Alternatives

SELLAS Life Sciences Group, Inc.  (SLS) 
Last sellas life sciences group, inc. earnings: 11/14 04:41 pm Check Earnings Report
PDF Phase 1/2 basket trial of lead clinical candidate, galinpepimut-S (GPS), plus Keytruda® (pembrolizumab) ongoing; Phase 3 registrational study for GPS monotherapy in acut [Read more]